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ABSTRACT
The importance of interprofessional education (IPE) in continuing medical education and professional
development has long been recognised by health organisations and academic societies, benefiting not
only patient outcomes and interprofessional relationships but also overall health systems and work-
force shortage. We report on the outcomes of an Australian IPE activity on medication-overuse head-
ache (MOH) with general practitioners (GPs) and community pharmacists as learners. The design of the
activity, which followed the predisposing–enabling–reinforcing instructional framework by Green and
Kreuter, aimed to: (1) improve knowledge and foster a willingness in GPs and pharmacists to work
collaboratively to enhance the prevention, diagnosis and management of MOH; and (2) address their
educational gap by demonstrating the utility of a blended learning IPE strategy onMOH. Integrated into
the activity was an assessment of its effectiveness and impact to instil change in the participants’
knowledge of MOH, attitude and willingness to treat, and clinical practice behaviours of GPs and
pharmacists to work together. The learners gained knowledge and confidence in diagnosing and
managing MOH and in their ability to educate patients. The IPE approach suited the activity and was
valued by the participating GPs and pharmacists, who seldom experience such learning formats.
However, for educational providers in Australia, developing and deploying an independent medical
education (IME) programme can be challenging. Providers of IMEs need to be aware of the potential
pitfalls when competing with pharmaceutical-company-sponsored and delivered programmes.
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Introduction
Interprofessional education and collaboration
The World Health Organization (WHO) recognises
the importance of interprofessional collaboration in
education and practice to mitigate the shortage of
global health workforce, to strengthen health systems
and improve patient outcomes [1]. The Society for
Academic Continuing Medical Education describes
interprofessional education (IPE) as “an intervention
where the members of more than one health or social
care (or both) profession learn interactively together,
for the explicit purpose of improving interprofes-
sional collaboration or the health/well-being (or
both) of patients/clients” [2, p. S66]. A Cochrane
review has shown IPE to have positive outcomes in
the areas of diabetes care, emergency department
culture, procedures and patient satisfaction, team
behaviour in operating rooms, care management in
cases of domestic violence and mental health practi-
tioner competencies [3].
Traditionally, professional learning in the health
sciences occurs in monodisciplinary educational systems,
but global trends as identified by the WHO and the need
for new models of care due to the growing prevalence of
chronic conditions led to reforms in health professional
education [4]. In Australia, the national standards body
for medical education, training and continuing profes-
sional development (CPD), the Australian Medical
Council, requires a range of teaching and learning
approaches, one of which is “working with interdisciplin-
ary and interprofessional teams” [5, p. 12]. And while
many universities include IPE and interprofessional
learning in their health and social care programmes, the
content is general in nature; learning outcomes, including
benefits to patients, are not formally assessed [4,6]. In
countries such as the US and Canada where learning
outcomes are routinely assessed, interprofessional CPDs
have been shown to improve the participants’ under-
standing of the roles of different professions, resulting
in improved respect and collaboration [7,8]. In 2016,
Dunston et al. [9] submitted a report to the Australian
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government recommending embedding IPE into accred-
itation and CPD requirements for professional
registration.
MOH in primary care
Medication-overuse headache (MOH) and other recur-
rent headaches are a public health concern because of the
disability and ill-health they cause in 1–2% of the popula-
tion [10]. However, more worrying is that people affected
are primarily self-treating without consulting a health
care professional. Poor public awareness and lack of
knowledge among healthcare providers have been iden-
tified as barriers to effective care [11]. Peters et al. [12]
highlighted the importance of healthcare practitioners
being well informed about diagnosis and management
of headaches, especially GPs because of their long-term
relationship with patients. In addition, Giaccone and
colleagues [13] showed that based on worldwide data,
community pharmacists can also play a crucial role in
the management of chronic headaches, particularly due
to their knowledge of prescription and over-the-counter
(OTC) medications and their easy access to patients.
However, effective outcomes are only possible with “ade-
quate and continuous training on both the management
of therapies and the relationship with the physicians and/
or patients” [12, p. S4].
Objectives
From a clinical perspective, we aimed not only to
enhance knowledge, but also to foster a positive atti-
tude in GPs and pharmacists towards working colla-
boratively to enhance the prevention, diagnosis and
management of MOH. Our educational aim was there-
fore to address this educational gap by demonstrating
the utility of a blended learning IPE strategy on MOH,
delivered nationwide to GPs and pharmacists in the
primary care setting.
Methods
Using broad theories of constructivism and behaviourism
to cultivate a collaborative and authentic online blended
learning, interprofessional experience with intended
behavioural change [14], we designed and deployed the
programme, Medication Overuse headache: educaTion
in dIagnosis, preVention, mAnagement and paTient
Education (MOTIVATE). The programme arose from a
grant received by In Vivo Academy (IVA) – an
Australian-based, not-for-profit, accredited education
provider to the Royal Australian College of General
Practitioners (RACGP).1 Recruiting participants all over
Australia, MOTIVATE extended the IPE model to a
primary care audience of GPs and community pharma-
cists. It tackled an often under-recognised and poorly
managed medication-induced condition with the key sta-
keholders who could effect change.
In this paper, we report on the interprofessional
nature as well as the instructional framework and
blended design of MOTIVATE and assessed the areas
in the programme that worked well for the education
of these healthcare professionals involved in the care of
people with headaches, and the improvements that
may guide future IPE programmes. Learnings from
this activity are expected to benefit other CME provi-
ders, faculty, learners and funders of independent med-
ical education (IME) programmes.
Needs assessment
Between September 2013 and February 2014, IVA con-
ducted two needs assessment surveys: one for GPs and
another for pharmacists. The GP survey was distributed
to about 3000 GPs in IVA’s database, while the pharma-
cist survey was advertised to approximately 5000 mem-
bers of the Australian College of Pharmacy (ACP)
through press releases in their newsletters distributed in
December 2014, January and February 2015.
In the GP survey, we explored the prevalence of
different types of headaches in the respondents’ own
practices and their confidence in diagnosing and mana-
ging patients with headache. We also assessed their per-
ceived knowledge of the prevalence and incidence of
MOH, their knowledge of the International Headache
Society guidelines on the prevention, diagnosis and man-
agement of MOH and their level of confidence in their
ability to identify MOH or the risk of MOH.
The pharmacist survey explored the pharmacists’
knowledge of MOH, their ability to detect warning
signs of MOH and their confidence to provide infor-
mation and advice to their customers about MOH and
motivate them to consult their GPs.
While the results of the needs assessment surveys were
used to guideMOTIVATE’s programme design and struc-
ture, a detailed report is beyond the scope of this paper.
Programme design and structure
Based on the above needs assessments, GPs and phar-
macists would benefit from an IPE CPD activity on
MOH. IVA and an expert steering committee, com-
posed of primary and specialist care providers, planned
and developed the IPE CPD programme MOTIVATE
using the criteria of the RACGP for an active learning
module (ALM). This “provide[s] structured, quality
2 M. L. VAN DRIEL ET AL.
education opportunities directed to achieving demon-
strable changes in the performance, knowledge, skills,
behaviours, and attitudes” [15, p. 32] The ALM design
is similar to the predisposing–enabling–reinforcing
instructional framework by Green and Kreuter [16,17]
that facilitates the adult learning process through a
learning cycle of: self-reflection, planning, action,
review and again, planning. As such, it consists of: (a)
a predisposing activity that provides an opportunity for
participants to reflect on their current clinical practice;
(b) a structured learning activity of at least 6 hours,
covering both a person approach to enhance profes-
sional competence (behaviour, attitude, skills and
knowledge) and a system approach that focuses on
team and procedural processes to safeguard patient
safety; and (c) a reinforcing activity that consolidates
learning [14]. This also integrates well with the five-
stage physician learning model described by Moore
et al. [16]: (1) recognising an opportunity for learning;
(2) searching for resources for learning; (3) engaging in
learning to address an opportunity for improvement;
(4) trying out what was learned; (5) incorporating what
was learned. The integrated outcomes assessment was
structured based on Moore’s framework, which
described seven levels of outcomes: 1 – Participation;
2 – Satisfaction; 3 – Knowledge; 4 – Competence; 5 –
Performance; 6 – Patient health; 7 – Community
health [16].
The MOTIVATE programme’s structure and con-
tent were as follows:
● Predisposing activity/pre-work – a short question-
naire (available online or paper-based), which
required participants to recall a patient/client who
presented with frequent headaches or often sought
pain medication for headaches in their practice or
pharmacy, and describe how headache histories
were obtained, how these patients were diagnosed,
treated, managed and whether they were referred
for speciality care. This aimed to help the partici-
pants “recognise a teachablemoment” [16, p. 5], and
an interest to pursue the subsequent modules.
● Module 1: Fundamental concepts of MOH – a 2-
hour online course, with case-stemmed, multiple-
choice and short-answer questions, short videos
of an MOH expert and a 20-item quiz to test their
knowledge at the end. This module covered the
epidemiology of MOH, the diagnostic criteria,
patterns of MOH, managing withdrawals, identi-
fying patients at risk and educating patients.
● Module 2: MOH: a case-study approach – a 2-
hour evening meeting held in major cities in
Australia; two of the 20 meetings were also
made available as live or archived webinars.
Facilitators at all Module 2 meetings and webinars
were neurologists with interest and expertise in
chronic headaches. This module allowed engage-
ment with other participants and opportunities to
try out what was learned from Module 1 in a safe
environment of case-based learning. It also served
as an opportunity to obtain feedback from the
neurologist who stood as facilitator, thus learning
the difference between “what they are doing and
what they should do to improve” [16, p. 5] phy-
sician competence (Outcomes level 4 of the
Moore framework) [10]. All participants received
booklets, which included all the key points of the
activity, and enough space to record feedback
from facilitator and co-participants.
● Module 3: Back at practice – a 2-hour combina-
tion of online and practical application of learning
how to obtain a comprehensive headache history.
This module allowed participants to apply their
learning in their practice. We provided them with
key pieces of information for use at point of care
such as MOH identification flowchart, quick
references for motivational interviewing, MOH
patient/client education checklist and headache
history forms.
● Reinforcing activity/post-work – a combination of
a practical activity and an online form, requiring
participants to ask patients who presented with
frequent headaches, migraine or possibly MOH,
to complete a self-administered questionnaire,
then have participants answer questions online.
This activity required participants to reflect on
the patients’ responses about their frequent head-
aches and their treatment, readiness to accept
their condition and to shift treatment, and their
fears and concerns about their condition, side
effects, withdrawal and tolerance. This also
allowed participants to reflect on the educational
gaps that still need to be addressed, both for the
healthcare professionals and the patients, and set
off a continuous learning process and self-
improvement.
The content of the programme was based on a review
of the literature conducted by IVA staff and informed
by experts in the field. A steering committee, consisting
of a neurologist/headache specialist, a GP, two phar-
macists and a professor of psychology, was formed to
discuss the content and critically review all materials.
Programme development and module creation took
approximately 8 months. IVA finalised the contents
for the online components and face-to-face meeting,
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wrote the promotional materials and invitations, and
directly deployed the invitations to the targeted parti-
cipant audience via fax and email.
MOTIVATE was approved by the RACGP Quality
Improvement & Continuing Professional Development
programme as an ALM and by the Australian College
of Rural and Remote Medicine (ACRRM) as a Planned
Reflective Professional Development activity. The three
MOTIVATE modules were also accredited individu-
ally. The ACP also accredited the individual compo-
nents of the programme.
The learning objectives of the MOTIVATE pro-
gramme were to:
● define MOH including the agents that are likely to
cause them based on the International
Classification of Headache Disorders, 3rd edition
(ICHD-III) diagnostic criteria [18];
● identify patients susceptible to MOH;
● develop integrated prevention and management
skills, such that when MOH is recognised:
○ pharmacists are able to motivate patients to
seek the help of GPs, and
○ GPs are able to develop an appropriate manage-
ment plan and effectively communicate this to
the patient; and
● put a system in place so that patients are made
aware of their susceptibility or risk of MOH.
Participants
GPs who have attended CPD activities previously
developed by IVA, who agreed to be contacted for
future activities and who practise in close proximity
to the meeting venues were invited by email or fax
between February and July 2015 to register for the
MOTIVATE programme. Identified using a simple
Google search, GP surgeries and pharmacies within a
10 km radius of a city meeting venue or up to within
100 km radius of a rural meeting venue (due to rural
Australia’s vastness and sparse population) were sent
fax invitations, and GPs and pharmacists interested in
the programme were asked to return the faxed form or
to register on the website, www.motivate.org.au.
MOTIVATE was listed on the RACGP (https://www.
racgp.org.au) and ACRRM (http://www.acrrm.org.au)
websites, and advertised on the electronic newsletters
distributed by the ACP to its members.
Registered participants were advised to complete the
predisposing activity and online Module 1 before
attending Module 2 or the 2-hour evening meeting in
their area. After Module 2, they were instructed to log
back into the programme website to complete Module
3 and the reinforcing activity. All participants were
given a deadline of 30 September 2015 to complete
the entire programme.
Outcomes evaluation design, collection and
analyses
Integrated into the MOTIVATE programme was an
assessment of the effectiveness and impact of the pro-
gramme to instil change in participant MOH knowledge,
attitude and willingness to treat, and clinical practice beha-
viours. We evaluated the programme with a mixed-meth-
ods approach using responses from the predisposing
activity (pre-work), evaluation forms, reinforcing activity
(post-work) and a qualitative assessment, in which parti-
cipants were independently contacted for interviews to
obtain an in-depth understanding of changes implemented
in clinical practice, and of facilitators and/or barriers to
these changes. Participants provided informed consent
(either written or online) for their survey or interview
data to be used for evaluation and research purposes. The
programme evaluation was approved by an independent
Institutional Review Board (IRB) consistent with ethical
principles outlined in the Australian National Statement
on Ethical Conduct in Research Involving Humans (2007),
to ensure anonymity of participants and confidentiality of
the information collected (Protocol number 17: 206; IRB
Services Ltd., a Chesapeake IRB company).
Participant data for outcomes assessment were col-
lected at several points in the programme:
(1) pre-assessment: baseline data from the predis-
posing activity forms;
(2) immediate-post survey: participants completed an
evaluation form upon completion of the full ALM
programme to measure satisfaction, perceived
achievement of the learning objectives and fulfil-
ment of their learning needs, their intention to
apply learnings to clinical practice, and self-
reported confidence and change in knowledge
compared with the needs assessment; and
(3) 2-months-post qualitative assessment: eight par-
ticipants who provided consent to be contacted
after completing the programme were inter-
viewed telephonically using a 45-minute semi-
structured discussion guide to assess knowledge
maintenance, self-reported confidence and self-
reported application of learnings to clinical
practice.
In addition, 30-minute semi-structured telephone
interviews were held with members of the programme’s
organising team, steering committee and a meeting
facilitator as formative assessment to identify what
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worked well and what needed improvement in each of
the components of the programme, particularly in the
planning, development, deployment, recruitment and
enrolment. Internal and external perceptions of the
initiative and the collaborative process as a whole
were also evaluated.
Control data were obtained via the pre-post evaluation
design. Quantitative data were analysed using SPSS 22.0
software (SPSS, Chicago, IL) and reported as frequencies
and cross-tabulations. Using a variation of thematic ana-
lysis (N-Vivo 7.0 software; QSR International, Cambridge,
MA), qualitative data were analysed using a four-step
approach: (1) codes identified based on literature review
and the interviewer’s debriefing; (2) transcripts coded
according to the developed coding structure; (3) new
codes developed for data that did not fit the pre-defined
codes; and (4) key emerging themes identified from the
data [19,20]. Aggregate data collected through both quan-
titative and qualitative methods were triangulated, thus
ensuring a more comprehensive report on the outcomes
of the programme. Findings were then classified based on
Moore’s outcomes framework described above [16].
Results
Participation (level 1)
Between November 2014 and July 2015, IVA
received a total of 624 registrations for the
MOTIVATE programme across Australia (Figure 1).
Three hundred participants completed both the pre-
disposing activity and Module 1 (179 GPs, 121 phar-
macists); of these, 147 proceeded to complete
Module 2 (67 GPs, 80 pharmacists), 137 continued
to Module 3 (102 GPs and 35 pharmacists), and 132
eventually completed the entire programme includ-
ing the reinforcing activity (98 GPs and 34 pharma-
cists). Although we encouraged the sequential
completion of the modules, we allowed 52 partici-
pants who have completed only the predisposing
activity to attend the meeting (Module 2) and asked
them to complete Module 1 after the meeting if they
were interested in obtaining 40 Category 1 points; 25
participants attended only Module 2.
Satisfaction and knowledge – self-reported survey
(level 2 and levels 3a/3b)
Based on the responses to the immediate-post survey, 80%
of GPs (n = 98) and 82% of pharmacists (n = 34) on
average felt that each of the learning objectives was fully
met (Figure 2); 83% GPs and 85% of pharmacists reported
that their learning needs were entirely met (Figure 3); and
91% of GPs and 85% of pharmacists rated MOTIVATE as
entirely relevant to their practice (Figure 4).
Some of the verbatim feedback from the immediate-
post survey with regard to satisfaction and knowledge
include:
Figure 1. Registration, actual participation and completion of programme. (GP = general practitioners, Ph = pharmacists).
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“I would like to thank everyone involved in preparing
this comprehensive course which has been very educa-
tional it has changed my practice for the management
of headache patients” – GP
“Thank you for this session, very informative and
educational. I had been researching this topic myself
and was excited when I received the fax/notification
for this talk” – GP
“This was a great programme that made me think and
was the best programme I have done for some time” –
GP
“Excellent programme for [a] common topic” – GP
Figure 2. Perceived achievement of learning objectives. *One GP did not answer this part of the evaluation. Thus, the total is only
131 participants for this learning objective.
Figure 3. Degree to which learning needs of participants were met.
Figure 4. Degree of activity’s relevance to participants’ practice.
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“I enjoyed the combination of pharmacist and GP
participants” – GP
“Good for pharmacist learning” – pharmacist
“Publicity to involve GPs in the project was limited,
which was a pity” – pharmacist
Assessment of changes in knowledge showed that
80% of all participants post-MOTIVATE participation
correctly identified all four withdrawal symptoms of
worsening headaches, hypotension, tachycardia and
insomnia, compared with our needs assessment,
which showed 50% of GPs reporting not so or not at
all confident in knowledge of withdrawal symptoms.
Improvement in knowledge was also indicated by a
shift from 12% who scored incorrectly in the needs
assessment to 0%, that is, no one gave an incorrect
response to the symptoms of MOH (Figure 5).
Around 98% of participants reported making at least
one change to their practice, and four of the most
frequently reported changes include: (1) more regular
tracking of patient medication; (2) improved patient
education and communication; (3) more regular/thor-
ough headache history; (4) implemented new tools
such as questionnaires and checklists (Figure 6).
Participants also reported increased confidence in
diagnosing headaches in general, in identifying patients
at risk of MOH, in their ability to educate or inform
patients about MOH, and in setting up appropriate
referral systems to headache specialists, if needed.
(Figure 7)
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Figure 5. Assessment of change in knowledge (MOH withdrawal symptoms).
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Figure 6. Changes most frequently reported by programme participants.
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Competence (level 4)
Eight participants (7 GPs; 1 pharmacist) were inter-
viewed 2 months after their completion of the pro-
gramme to explore maintenance of knowledge, self-
reported confidence and application of learnings to
clinical practice. All participants who engaged in the
2-month post assessment reported increased awareness
and knowledge of MOH after the programme.
“Before I entered the programme I really hadn’t
thought very much about MOH, it was never men-
tioned in medical school” – GP
“I really didn’t dwell on it beforehand at all. I don’t
know that I really warned people prior to doing the
programme about the potential for the problem.
Whereas now I do.” – GP
“I’d heard of the concept of MOH but I didn’t really
know the details. What to describe to patients, what
sort of things I should be looking for, what are the risk
factors. So pretty much all of it was new to me.
Changed the way that I look at analgesia.” –
pharmacist
Self-reported confidence improved:
“I am more confident. Right now I am really more
confident about my diagnosis.” – GP
Participants reported taking more thorough headache
histories 2 months after attending the programme. A
GP commented:
“I now take a basic headache history. I just quantify it
more than I did before. So instead of vaguely ‘what
medication do you take?’ I actually ask them how
much and when and so on. That’s the main difference.
And obviously warn them if they are taking OTC
medications that it is not without risk and give them
strategies so that they don’t fall into the trap.”
A pharmacist stated:
“Before I would not have picked [MOH] up whereas
now I’m on the hunt for it. So when they say they’re
using a lot of PRNs or a lot of analgesia I’ll say ‘How
much are you using? If you stop taking it do you get
rebound headaches?’ It’s given me something more to
talk about with the patients.”
Participants commented that completing Module 2 (“A
case-study approach”) and receiving feedback from the
neurologist facilitator sufficiently addressed their learn-
ing needs. Especially, if MOH was not seen as a prior-
ity, completing Module 3 (“Back at practice”) and the
reinforcing activity was considered unnecessary work.
Some GPs also mentioned they did not need to com-
plete the entire programme, as they already had
enough points to meet their CPD requirements for
the triennium.
Formative assessment by the steering committee
and organisers
The formative assessment revealed that a low comple-
tion rate by participants may be due to lack of aware-
ness and prioritisation of MOH in primary care, some
issues related to the current CME context in Australia,
the lack of understanding by the target audience of the
programme focus and participation requirements,
technical difficulties with the online modules and per-
ceived relevance to select programme modules to prac-
tice. (Table 1) In addition, the formative data also
provided insights with respect to the challenges inher-
ent in deploying an IME activity in Australia, notably,
independent of any support by industry medical liai-
sons or sales representatives.
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Figure 7. Levels of confidence after completing the entire programme.
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Discussion
The MOTIVATE programme was designed to
enhance insights and knowledge, and bring about
change in clinical practice behaviours among GPs
and pharmacists to work together in order to
enhance prevention, diagnosis and management of
MOH. Moreover, the programme was designed and
deployed independently according to the parameters
of an IME, and followed an IPE CPD model
wherein GPs and pharmacists were trained together
using the predisposing–enabling–reinforcing
instructional framework.
The participants were found to have increased
knowledge and improved confidence in diagnosing
headaches in general, identifying patients at risk of
MOH, including its likely causes based on the ICHD-
III criteria and in identifying patients susceptible to
MOH. They also gained confidence in their ability to
educate or inform patients about MOH and setting up
appropriate referral systems, if needed.
The response to MOTIVATE was positive, in terms
of the relevance and uniqueness of the interprofes-
sional nature of the activity. The outcomes analysis
indicated that the activity’s objectives were fully met,
that the activity was entirely relevant to the partici-
pants’ practice, and that participants’ learning needs
were met. The participants recognised the value of
the educational programme on a common condition
such as chronic headache and the consequences of
medication overuse if not detected. Both GPs and
pharmacists welcomed the interprofessional nature of
the activity.
The IPE approach suited the topic and the activity
well, as it highlighted the roles and responsibilities of
and between GPs and pharmacists. According to
Pullon’s [21] research findings, working together for
the common goal of patient health and recognising
their respective skill sets leads to respect and interpro-
fessional trust. Change in clinical practice behaviours
as a result of IPE occurs when: (1) the education
Table 1. Formative assessment of casualties.
Under-recognition of MOH in primary care • Lack of awareness of MOH
• Not seen as a priority issue
Issues related to current continuing medical education context in
Australia • Recruitment of participants for educational programmes traditionally done by
industry representatives through their relationships with physicians
• Challenging to get people to understand nature of the programme (i.e.
Independent Medical Education)
• Without this pre-defined network of potential participants, IVA required
additional resources to identify/develop lists of participants
Low completion rate compared with the number of participants who
registered and attended the face-to-face meeting (Module2)
• Due to the participants’ view that completing Module 2 and receiving feedback
from the neurologist facilitator were enough and had already met their
learning needs.
• Some GPs do not feel the need to complete the entire programme as they have
earned enough points to meet the RACGP requirements
Lack of understanding by target audience of the programme focus
and participation requirements
• It was reported that invitation materials could have been clearer:
∘ The programme focus was not headaches but more specifically MOH
∘ Amount of effort required from participants (i.e. 6 h of learning plus
predisposing and reinforcing activities) to earn 40 Category 1 points could
have been better defined
∘ Description of interprofessional aspect of the programme could have been
more clear
• Completion of the programme requires participants to return to practice and
apply programme learnings, but not all participants had the opportunity to
apply programme learnings to an MOH patient in practice
Technical difficulties with the online modules • Some course responses appeared to not register and participants would need
to restart
• Could have impacted participant’s willingness to continue to complete the
programme
Perceived relevance of select programme modules to practice • Steering Committee members reported a review of the final programme
materials would have been beneficial to smooth out any remaining issues:
∘ A last review of the content would have allowed for the additional
comments:
∘ Inclusion of more interactive components for the live session (Module 2)
∘ Adapting content of Module 1 to ensure its relevance for primary care
providers
1The RACGP is a professional organisation of about 30,000 GPs in Australia. It supports GPs, GP registrars and medical students through education, training
and research. (http://www.racgp.org.au/yourracgp/organisation/).
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emphasises the participants’ common goals or experi-
ence; (2) encourages respect and trust; and (3) provides
an opportunity to share differing opinions and experi-
ences in a safe environment. This allows a coherent,
collective decision rather than just a consensus to be
reached [22]. These conditions were observed during
the face-to-face meetings and self-reported by the par-
ticipants, but we were unable to link this to actual
change in clinical behaviours, for example by way of
observations in patient care setting or charts.
While countries such as the Netherlands have a
long tradition of GP–pharmacist IPE activities
[23,24], these are not common in Australia, based on
advertised educational activities both in the RACGP
and ACP websites and also in comments we received
from our participants. Because of the plethora of CPD
activities offered to GPs, usually sponsored by phar-
maceutical companies, GPs are accustomed to attend-
ing symposia and workshops where they earn CPD
points to meet their respective college requirements.
Australian pharmacists, on the other hand, do not
have the same opportunities with most of their CPD
activities being self-directed learning. The interaction
and the collaboration among GPs, pharmacists and
neurologists were therefore appreciated by all partici-
pants. Collaborations between GPs and pharmacists
were also viewed favourably in studies outside
Australia [19,20].
There were challenges with recruitment of partici-
pants, especially GPs. The pharmaceutical industry uses
representatives who have personal relationships with
doctors and pharmacists and use mailing lists to alert
their clients to upcoming education opportunities.
Without this type of assistance, we had to generate a
list of the target group and send out invitations and
connect with them effectively through simple, direct
but attractive messaging. In the absence of face-to-
face social marketing, this was challenging through
emails and faxes.
We received a total of 624 registrations, but only
20% completed the entire programme; a large part of
the attrition occurred after attending the face-to-face
meeting. This may be due to some of the participants’
view that completing the programme after Module 2
(“A case-study approach”) and receiving feedback from
the neurologist facilitator were sufficient to meet their
learning and CPD requirements. If participants did not
see MOH as a priority issue, completing Module 3
(“Back at practice”) and the associated reinforcing
activity would be considered unnecessary work.
Therefore, it is important to understand the needs of
the target audience and develop a flexible programme
that caters for different needs and interests.
To our knowledge, our study is the first to report on
an IPE programme with GPs and pharmacists in
Australia. However, there are some limitations to its
generalisability, as the response rate decreased at each
point of measurement due to attrition of the enrolled
participants. But this attrition reflects a real-life sce-
nario and provides pragmatic evidence. The qualitative
data reveal interesting insights to understand the com-
plex reality of pushing education out to health profes-
sionals in a context where a plethora of (often industry-
sponsored) education is freely available.
Face-to-face meetings remain the most popular form
of CPD activity in Australia despite the growing popu-
larity of online learning courses. Yee et al. [25] reported
that 83% prefer face-to-face lecture-based formats com-
pared with 55% who prefer online self-education.
However, in a large but sparsely populated country like
Australia, a blended approach to learning is more finan-
cially viable and can be as effective as the traditional face-
to-face modes. Blended learning has also consistently
shown effectiveness in knowledge acquisition compared
with no intervention at all [26,27]. It has demonstrated
improvements in learning outcomes in graduate studies
where curricula are based on adult learning theory
[8,9,28,29]. However, no evidence, as yet, has demon-
strated the extent to which deep learning can result
from a short-term learning scenario, such as CPD activ-
ities where adult learning principles apply. Although
CPD activities are required by all healthcare professional
organisations in Australia, the learners are still the ones to
decide and manage their own learning. For example,
some participants perceived the online component of
the programme to be difficult and so decided not to
complete the online modules but only attended the face-
to-face meeting.
Developing and deploying an IME programme in
Australia, being a new concept, had its challenges. Even
though the authors of this paper have many years of
combined experience in education, training and CPD
development, the MOTIVATE programme was a new
learning experience. Independent education providers
need to be aware of the potential pitfalls when competing
with pharmaceutical-company-sponsored and delivered
programmes. However, it is likely that the future of accre-
dited CPD education in Australia will follow the example
of other countries, where the concept of education plan-
ning and content will be conducted entirely independently
of pharmaceutical industry involvement. The value of IPE
is recognised not just by large organisations such as the
WHO and governments, but by the learners themselves.
Therefore, postgraduate continuing professional education
should consider including all relevant professional disci-
plines in education activities.
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